MDR E. coli immunogen

US11529405B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Eszter Nagy · Wien, AT
• Gabor Nagy · Redmond, US
• Valeria SZIJARTO · Wien, AT
• Zoltán Magyarics · Wien, AT
• Irina MIRKINA · Wien, AT
• Luis Gauchalla · Wien, AT
• Adriana BADARAU · Wien, AT
• Gerhild Zauner · Wien, AT
• Jolanta Lukasiewicz · Wrocław, PL

Key dates

• Filing date: Feb 4, 2021
• Grant date: Dec 20, 2022
• Expiry date: Feb 4, 2041

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.